TriSalus Life Sciences, Inc.
Q3 2025 13F Holders
Symbol
TLSI
CUSIP
89680M101
Type
Equity
Class
COM
Num filings
58
Total reported value, excl. options
$44.5 M
Compare 2025 Q3 to
2026 Q3
2026 Q2
2026 Q1
2025 Q4
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
Manager
Report Date
Value ($000)
Shares
Option Type